TABLE 5.
Parameter for group | MCP
|
CRM197
|
||||||
---|---|---|---|---|---|---|---|---|
Intramuscular naive | Nasal
|
Total nasalc | Intramuscular naive | Nasal
|
Total nasalc | |||
Naivea | Preimmunizedb | Naivea | Preimmunizedb | |||||
No. | 6 | 13 | 17 | 30 | 6 | 13 | 17 | 30 |
GMC (μg/ml) | ||||||||
IgG1 | 4.3 | 3.3 | 5.6 | 4.4 | 66.4 | 19.4 | 30.6 | 25.1 |
IgG2 | 10 | 14.7 | 16.5 | 15.7 | 21.7 | 23.3 | 22.6 | 22.9 |
IgG3 | 0.56 | 0.48 | 1.0 | 0.7 | 0.4 | 0.29 | 0.23 | 0.25 |
IgG4 | 1.1 | 1.4 | 1.2 | 1.3 | 92.0 | 43.3 | 39.1 | 40.9 |
% of total IgGd | ||||||||
IgG1 | 27 | 17 | 23 | 20 | 37 | 22 | 33 | 28 |
IgG2 | 63 | 74 | 68 | 71 | 12 | 27 | 24 | 26 |
IgG3 | 4 | 2 | 4 | 3 | 0.2 | 0.3 | 0.2 | 0.3 |
IgG4 | 7 | 7 | 5 | 6 | 51 | 50 | 42 | 46 |
Between-subclass differencese | ||||||||
IgG1 vs IgG2 | NS | *** | * | *** | NS | NS | NS | NS |
IgG1 vs IgG3 | * | *** | *** | *** | * | *** | *** | *** |
IgG1 vs IgG4 | NS | NS | *** | *** | NS | NS | NS | NS |
IgG2 vs IgG3 | *** | *** | *** | *** | NS | *** | *** | *** |
IgG2 vs IgG4 | ** | *** | *** | *** | NS | NS | NS | NS |
IgG3 vs IgG4 | NS | * | NS | NS | ** | *** | *** | *** |
Groups 1 and 3.
Group 2.
Groups 1, 2, and 3.
May not total 100% due to rounding.
Bonferroni's multiple-comparison test: NS, not significant (P > 0.05); *, P < 0.05; **, P < 0.01; ***, P < 0.001.